E-Cadherin Antibodies: Unveiling the Complex Link Between Cell Adhesion and Tumor Metastasis

1. Literature Information
Research Focus: Exploration of E-Cadherin’s role in cell adhesion, signaling regulation, epithelial-mesenchymal transition (EMT), dual functions in tumor progression, and the applications of E-Cadherin antibodies in research and diagnosis.
Core Innovation: Validation of E-Cadherin as a key regulator of cell adhesion and EMT—with its downregulation serving as a hallmark of tumor metastasis—while E-Cadherin antibodies enable precise detection to decipher tumor progression mechanisms and guide clinical assessment.

2. Research Background
E-Cadherin, a calcium-dependent single-pass transmembrane protein of the cadherin family, is critical for maintaining epithelial tissue integrity. It mediates homophilic cell-cell adhesion through extracellular calcium-binding domains and connects to the cytoskeleton via intracellular interactions with catenins. Beyond structural support, E-Cadherin regulates signaling pathways (e.g., Wnt/β-catenin) and cell polarity. In tumor biology, E-Cadherin exhibits functional duality: its loss promotes tumor detachment and metastasis, yet it may facilitate metastatic colonization in certain contexts. EMT—marked by E-Cadherin downregulation—is a key step in tumor progression. E-Cadherin antibodies enable accurate detection of its expression and localization, becoming indispensable tools for studying cell adhesion, EMT, and tumor metastasis.

3. Research Approaches
To dissect E-Cadherin’s role in tumor metastasis, the research team adopted a multi-dimensional strategy:
Mechanistic Characterization: Investigating E-Cadherin’s structural basis for cell adhesion and crosstalk with signaling pathways (Wnt/β-catenin).
EMT Regulation Analysis: Evaluating E-Cadherin downregulation during EMT and its modulation by transcription factors (Snail, Slug, Twist, ZEB).
Tumor Progression Studies: Exploring E-Cadherin’s dual functions in tumor initiation, invasion, and metastatic colonization.
Antibody Application Validation: Assessing E-Cadherin antibodies in IHC, functional intervention, and circulating tumor cell detection.
Translational Research: Investigating E-Cadherin as a prognostic biomarker and potential therapeutic target.

4. Research Outcomes
4.1 Core Role of E-Cadherin in Cell Adhesion
Structural Features: Extracellular domain (EC 1-5) with calcium-binding sites; transmembrane region; intracellular domain interacting with α/β-catenins to link to the actin cytoskeleton.
Adhesion Mechanism: Homophilic binding between E-Cadherin molecules on adjacent cells forms stable intercellular junctions; cytoskeletal linkage reinforces adhesive strength and maintains cell polarity.

4.2 E-Cadherin in Cell Signaling Regulation
Wnt Pathway Crosstalk: Cytoplasmic β-catenin is sequestered by E-Cadherin complexes in resting cells; Wnt activation releases β-catenin for nuclear translocation and target gene regulation.
Multi-Level Regulation: Transcriptional suppression via E-box sequences in the CDH1 promoter; post-translational modifications modulating membrane localization and stability.

4.3 E-Cadherin Changes During EMT
EMT Hallmark: E-Cadherin downregulation reduces cell adhesion, enabling epithelial cells to acquire mesenchymal traits (enhanced migration/invasion).
Transcriptional Regulation: Snail, Slug, Twist, and ZEB bind the CDH1 promoter to inhibit expression—abnormal levels of these factors correlate with tumor aggressiveness.
Continuous Spectrum: E-Cadherin expression follows a gradient rather than an "on-off" switch, reflecting EMT’s dynamic nature.

4.4 Dual Roles in Tumor Progression
Metastasis Promotion: E-Cadherin loss allows tumor cells to detach from primary sites and invade surrounding tissues—correlating with poor prognosis in most epithelial cancers.
Metastatic Colonization: In some tumors (e.g., invasive ductal breast cancer), E-Cadherin expression facilitates metastatic niche formation and survival.
Context-Dependence: Roles vary by tumor type, microenvironment, and progression stage.

4.5 Research Applications of E-Cadherin Antibodies
Basic Research: Detect E-Cadherin expression, localization, and interactions; assess EMT status via IHC.
Functional Studies: Use function-blocking antibodies to simulate E-Cadherin loss and study effects on cell migration/invasion.
Clinical Translation: Identify circulating tumor cells; aid in differentiating epithelial tumors (carcinomas) from sarcomas.

4.6 Future Research Directions
Single-Cell Analysis: Reveal E-Cadherin’s role in tumor heterogeneity.
Real-Time Imaging: Visualize dynamic changes in E-Cadherin-mediated cell interactions.
Translational Strategies: Target E-Cadherin regulatory networks or downstream effectors for therapy; explore as a predictive biomarker.

5. Product Empowerment by ANT BIO PTE. LTD.
ANT BIO PTE. LTD.’s STARTER brand, a leader in recombinant antibodies, provides a high-performance tool for tumor research: the "S-RMab® E-Cadherin Recombinant Rabbit Monoclonal Antibody" (Catalog No.: S0B2112).

Key Roles of the Product:
Precise Detection: Exhibits high specificity for E-Cadherin with clear membrane staining in FFPE samples—enabling accurate assessment of cell adhesion and EMT status.
Research Versatility: Supports EMT research, tumor invasion/metastasis evaluation, and differential diagnosis of epithelial tumors (e.g., lobular vs. ductal breast cancer).
Core Advantages: Excellent staining stability, minimal batch variation, and clean background—ensuring reliable results for clinical and basic research.
Technical Support: Comprehensive IHC protocols, antigen retrieval solutions, and interpretation guidance facilitate standardized detection.

ANT BIO PTE. LTD.’s portfolio includes conjugated variants (Alexa Fluor® 488, Cy5) for fluorescence-based applications, expanding research flexibility.

6. Brand Mission
ANT BIO PTE. LTD. is dedicated to empowering global life science advancement through three specialized sub-brands: ABSIN (general reagents, ELISA kits), STARTER (antibodies), and UA (recombinant proteins). Leveraging advanced development platforms—including recombinant rabbit/mouse monoclonal antibody generation, PTM Pan-Modification Antibody Platform, and One-Step ELISA—we deliver high-quality, compliant products certified by EU 98/79/EC, ISO9001, and ISO13485. Our mission is to partner with research institutions, pharmaceutical companies, and clinical laboratories worldwide, providing innovative reagents and solutions that accelerate discoveries in tumor biology, cell adhesion, and precision medicine.

7. Related Product List

S0B0148	E-Cadherin Recombinant Rabbit mAb (Cy5 Conjugate) (S-438-5)	Host : Rabbit Conjugation : Cy5
S0B0145	E-Cadherin Recombinant Rabbit mAb (Alexa Fluor® 488 Conjugate) (S-438-5)	Host : Rabbit Conjugation : Alexa Fluor® 488
S0B2224	S-RMab® E-Cadherin Recombinant Rabbit mAb (SDT-438-5)	Host : Rabbit Conjugation: Unconjugated
S0B2112P	S-RMab® E-Cadherin Recombinant Rabbit mAb,PBS Only (SDT-R088)	Host : Rabbit
S0B2112	S-RMab® E-Cadherin Recombinant Rabbit mAb (SDT-R088)	Host : Rabbit

8. AI Disclaimer
This article is AI-compiled and interpreted based on the original work. All intellectual property (e.g., images, data) of the original publication shall belong to the journal and the research team. For any infringement, please contact us promptly and we will take immediate action.
 
ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs
At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.